Terms: = Leukemia AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
95 results:
1. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract] [Full Text] [Related]
2. Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia.
Mansour AG; Teng KY; Li Z; Zhu Z; Chen H; Tian L; Ali A; Zhang J; Lu T; Ma S; Lin CM; Caligiuri MA; Yu J
Blood Adv; 2023 Oct; 7(20):6225-6239. PubMed ID: 37379267
[TBL] [Abstract] [Full Text] [Related]
3. Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling.
Shah K; Al Ashiri L; Nasimian A; Ahmed M; Kazi JU
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902436
[TBL] [Abstract] [Full Text] [Related]
4. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
5. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
6. Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Sharma P; Kimler BF; O'Dea A; Nye L; Wang YY; Yoder R; Staley JM; Prochaska L; Wagner J; Amin AL; Larson K; Balanoff C; Elia M; Crane G; Madhusudhana S; Hoffmann M; Sheehan M; Rodriguez R; Finke K; Shah R; Satelli D; Shrestha A; Beck L; McKittrick R; Pluenneke R; Raja V; Beeki V; Corum L; Heldstab J; LaFaver S; Prager M; Phadnis M; Mudaranthakam DP; Jensen RA; Godwin AK; Salgado R; Mehta K; Khan Q
Clin Cancer Res; 2021 Feb; 27(4):975-982. PubMed ID: 33208340
[TBL] [Abstract] [Full Text] [Related]
7. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.
Yonekura K; Kusumoto S; Choi I; Nakano N; Ito A; Suehiro Y; Imaizumi Y; Yoshimitsu M; Nosaka K; Ohtsuka E; Hidaka M; Jo T; Sasaki H; Moriuchi Y; Ogata M; Tatetsu H; Ishitsuka K; Miyazaki Y; Ueda R; Utsunomiya A; Ishida T
Blood Adv; 2020 Oct; 4(20):5133-5145. PubMed ID: 33091125
[TBL] [Abstract] [Full Text] [Related]
8. Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia.
Moriguchi M; Koh H; Hayashi T; Okamura H; Nanno S; Nakashima Y; Nakane T; Imoto W; Yamada K; Kakeya H; Hino M; Nakamae H
J Infect Chemother; 2020 Oct; 26(10):1054-1057. PubMed ID: 32505444
[TBL] [Abstract] [Full Text] [Related]
9. Serum levels of selected cytokines and soluble adhesion molecules in acute myeloid leukemia: Soluble receptor for interleukin-2 predicts overall survival.
Kupsa T; Vanek J; Zak P; Jebavy L; Horacek JM
Cytokine; 2020 Apr; 128():155005. PubMed ID: 32006876
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and Fludarabine.
Podichetty JT; Brinda BJ; Nelson RP; Karr AH; Prasad NK; Quinney S; Foxworthy Scott S; Kiel PJ
Pharmacotherapy; 2020 Jan; 40(1):26-32. PubMed ID: 31742732
[TBL] [Abstract] [Full Text] [Related]
11. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
12. The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone.
Xiang J; Wang G; Xia T; Chen Z
Biomed Pharmacother; 2019 Jan; 109():2210-2217. PubMed ID: 30551478
[TBL] [Abstract] [Full Text] [Related]
13. PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes.
Ha YJ; Choi YS; Han DW; Kang EH; Yoo IS; Kim JH; Kang SW; Lee EY; Song YW; Lee YJ
Rheumatology (Oxford); 2019 Jan; 58(1):154-164. PubMed ID: 30204915
[TBL] [Abstract] [Full Text] [Related]
14. [Study on Immunophenotypes and Gene of Acute Lymphoblastic leukemia].
Zhao XF; Wang HY; Zhao X; Cheng HC; Li W; Liu SW; Qiu L; Ma J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):947-952. PubMed ID: 30111389
[TBL] [Abstract] [Full Text] [Related]
15. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
Takita J
Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
[TBL] [Abstract] [Full Text] [Related]
16. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract] [Full Text] [Related]
17. Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations.
Li F; Zhang X; Wang Y; Yang A; Zhang Z; Tang W; Zhong N; Shi H
BMC Cancer; 2018 May; 18(1):604. PubMed ID: 29843647
[TBL] [Abstract] [Full Text] [Related]
18. Intracavitary amphotericin B in the treatment of intracranial aspergillosis.
Kural C; Ozer MI; Ezgu MC; Mehtiyev R; Yasar S; Kutlay AM; Daneyemez MK; Onguru O; Erdogan E; Izci Y
J Clin Neurosci; 2018 May; 51():75-79. PubMed ID: 29506772
[TBL] [Abstract] [Full Text] [Related]
19. Low level of serum HDL-cholesterol with increased sil-2R predicts a poor clinical outcome for patients with malignant lymphoma and adult T-cell leukemia-lymphoma.
Komiya I; Tomoyose T; Ouchi G; Yara T; Higa S
Cytokine; 2018 May; 105():57-62. PubMed ID: 29459344
[TBL] [Abstract] [Full Text] [Related]
20. Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell leukemia.
Mohammed TO; Chagan-Yasutan H; Ashino Y; Nakayama W; Takahashi Y; Shimomura T; Fujimoto T; Watanabe Y; Niki T; Suzushima H; Hattori T
Tohoku J Exp Med; 2017 Mar; 241(3):201-208. PubMed ID: 28321034
[TBL] [Abstract] [Full Text] [Related]
[Next]
